Cytosolic prion protein is the predominant anti-Bax prion protein form: Exclusion of transmembrane and secreted prion protein forms in the anti-Bax function

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1783, Issue 10, 2008, Pages 2001-2012

  Lin, David T S ^a,b   Jodoin, Julie ^a,b   Baril, Michaël ^a,b   Goodyer, Cynthia G ^b   LeBlanc, Andréa C ^a,b  

^a Bloomfield Center for Research in Aging   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Apoptosis; Bax; Cytosolic prion protein; Neuroprotection; Prion; Secreted prion protein; Transmembrane prion protein

Indexed keywords

GREEN FLUORESCENT PROTEIN; MEMBRANE PROTEIN; MUTANT PROTEIN; PRION PROTEIN; PROTEASOME; PROTEIN BAX;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELLULAR DISTRIBUTION; CYTOSOL; ENZYME DEGRADATION; HUMAN; HUMAN CELL; MOUSE; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; PROTEIN SECRETION; SYRIAN HAMSTER; WILD TYPE;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL LINE; CELL MEMBRANE; CYTOSOL; HUMANS; MICE; MUTATION; NEURONS; PRIONS; PROTEIN BINDING;

MESOCRICETUS AURATUS;

EID: 50849114500     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2008.05.022     Document Type: Article

References (67)

1. Prusiner S.B. Prions. Proc. Natl. Acad. Sci. U. S. A 95 (1998) 13363-13383
2. Roucou X., and LeBlanc A.C. Cellular prion protein neuroprotective function: implications in prion diseases. J. Mol. Med 83 (2005) 3-11
3. Westergard L., Christensen H.M., and Harris D.A. The cellular prion protein (PrP(C)): its physiological function and role in disease. Biochim. Biophys. Acta 1772 (2007) 629-644
4. Weise J., Crome O., Sandau R., Schulz-Schaeffer W., Bahr M., and Zerr I. Upregulation of cellular prion protein (PrPc) after focal cerebral ischemia and influence of lesion severity. Neurosci. Lett 372 (2004) 146-150
5. Mitteregger G., Vosko M., Krebs B., Xiang W., Kohlmannsperger V., Nolting S., Hamann G.F., and Kretzschmar H.A. The role of the octarepeat region in neuroprotective function of the cellular prion protein. Brain Pathol 17 (2007) 174-183
6. Nishida N., Tremblay P., Sugimoto T., Shigematsu K., Shirabe S., Petromilli C., Erpel S.P., Nakaoke R., Atarashi R., Houtani T., Torchia M., Sakaguchi S., DeArmond S.J., Prusiner S.B., and Katamine S. A mouse prion protein transgene rescues mice deficient for the prion protein gene from Purkinje cell degeneration and demyelination. Lab. Invest 79 (1999) 689-697
7. Shmerling D., Hegyi I., Fischer M., Blattler T., Brandner S., Gotz J., Rulicke T., Flechsig E., Cozzio A., von Mering C., Hangartner C., Aguzzi A., and Weissmann C. Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell 93 (1998) 203-214
8. Walz R., Amaral O.B., Rockenbach I.C., Roesler R., Izquierdo I., Cavalheiro E.A., Martins V.R., and Brentani R.R. Increased sensitivity to seizures in mice lacking cellular prion protein. Epilepsia 40 (1999) 1679-1682
9. Rangel A., Burgaya F., Gavin R., Soriano E., Aguzzi A., and Del Rio J.A. Enhanced susceptibility of Prnp-deficient mice to kainate-induced seizures, neuronal apoptosis, and death: role of AMPA/kainate receptors. J. Neurosci Res 85 (2007) 2741-2755
10. Kuwahara C., Takeuchi A.M., Nishimura T., Haraguchi K., Kubosaki A., Matsumoto Y., Saeki K., Matsumoto Y., Yokoyama T., Itohara S., and Onodera T. Prions prevent neuronal cell-line death. Nature 400 (1999) 225-226
11. Brown D.R., and Besinger A. Prion protein expression and superoxide dismutase activity. Biochem. J 334 Pt 2 (1998) 423-429
12. Diarra-Mehrpour M., Arrabal S., Jalil A., Pinson X., Gaudin C., Pietu G., Pitaval A., Ripoche H., Eloit M., Dormont D., and Chouaib S. Prion protein prevents human breast carcinoma cell line from tumor necrosis factor alpha-induced cell death. Cancer Res 64 (2004) 719-727
13. Meslin F., Hamai A., Gao P., Jalil A., Cahuzac N., Chouaib S., and Mehrpour M. Silencing of prion protein sensitizes breast adriamycin-resistant carcinoma cells to TRAIL-mediated cell death. Cancer Res 67 (2007) 10910-10919
14. Meslin F., Conforti R., Mazouni C., Morel N., Tomasic G., Drusch F., Yacoub M., Sabourin J.C., Grassi J., Delaloge S., Mathieu M.C., Chouaib S., Andre F., and Mehrpour M. Efficacy of adjuvant chemotherapy according to prion protein expression in patients with estrogen receptor-negative breast cancer. Ann. Oncol 18 (2007) 1793-1798
15. Bounhar Y., Zhang Y., Goodyer C.G., and LeBlanc A. Prion protein protects human neurons against Bax-mediated apoptosis. J. Biol. Chem 276 (2001) 39145-39149
16. Roucou X., Giannopoulos P.N., Zhang Y., Jodoin J., Goodyer C.G., and LeBlanc A. Cellular prion protein inhibits proapoptotic Bax conformational change in human neurons and in breast carcinoma MCF-7 cells. Cell Death Differ 12 (2005) 783-795
17. Heitz S., Gautheron V., Lutz Y., Rodeau J.L., Zanjani H.S., Sugihara I., Bombarde G., Richard F., Fuchs J.P., Vogel M.W., Mariani J., and Bailly Y. BCL-2 counteracts Doppel-induced apoptosis of prion-protein-deficient Purkinje cells in the Ngsk Prnp(0/0) mouse. Dev. Neurobiol 68 (2008) 332-348
18. Heitz S., Lutz Y., Rodeau J.L., Zanjani H., Gautheron V., Bombarde G., Richard F., Fuchs J.P., Vogel M.W., Mariani J., and Bailly Y. BAX contributes to Doppel-induced apoptosis of prion-protein-deficient Purkinje cells. Dev. Neurobiol 67 (2007) 670-686
19. Leber B., Lin J., and Andrews D.W. Embedded together: the life and death consequences of interaction of the Bcl-2 family with membranes. Apoptosis 12 (2007) 897-911
20. Bounhar Y., Mann K.K., Roucou X., and LeBlanc A.C. Prion protein prevents Bax-mediated cell death in the absence of other Bcl-2 family members in Saccharomyces cerevisiae. FEMS Yeast Res 6 (2006) 1204-1212
21. Chae H.J., Kim H.R., Xu C., Bailly-Maitre B., Krajewska M., Krajewski S., Banares S., Cui J., Digicaylioglu M., Ke N., Kitada S., Monosov E., Thomas M., Kress C.L., Babendure J.R., Tsien R.Y., Lipton S.A., and Reed J.C. BI-1 regulates an apoptosis pathway linked to endoplasmic reticulum stress. Mol. Cell 15 (2004) 355-366
22. Roth W., Kermer P., Krajewska M., Welsh K., Davis S., Krajewski S., and Reed J.C. Bifunctional apoptosis inhibitor (BAR) protects neurons from diverse cell death pathways. Cell Death Differ 10 (2003) 1178-1187
23. Zanusso G., Petersen R.B., Jin T., Jing Y., Kanoush R., Ferrari S., Gambetti P., and Singh N. Proteasomal degradation and N-terminal protease resistance of the codon 145 mutant prion protein. J. Biol. Chem 274 (1999) 23396-23404
24. Mironov Jr. A., Latawiec D., Wille H., Bouzamondo-Bernstein E., Legname G., Williamson R.A., Burton D., DeArmond S.J., Prusiner S.B., and Peters P.J. Cytosolic prion protein in neurons. J. Neurosci 23 (2003) 7183-7193
25. Yedidia Y., Horonchik L., Tzaban S., Yanai A., and Taraboulos A. Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein. Embo J 20 (2001) 5383-5391
26. Ma J., and Lindquist S. Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation. Proc. Natl. Acad. Sci. U. S. A 98 (2001) 14955-14960
27. Roucou X., Guo Q., Zhang Y., Goodyer C.G., and LeBlanc A.C. Cytosolic prion protein is not toxic and protects against Bax-mediated cell death in human primary neurons. J. Biol. Chem 278 (2003) 40877-40881
28. Rane N.S., Yonkovich J.L., and Hegde R.S. Protection from cytosolic prion protein toxicity by modulation of protein translocation. Embo J 23 (2004) 4550-4559
29. Drisaldi B., Stewart R.S., Adles C., Stewart L.R., Quaglio E., Biasini E., Fioriti L., Chiesa R., and Harris D.A. Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation. J. Biol. Chem 278 (2003) 21732-21743
30. Ma J., Wollmann R., and Lindquist S. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 298 (2002) 1781-1785
31. Ma J., and Lindquist S. Conversion of PrP to a self-perpetuating PrPSc-like conformation in the cytosol. Science 298 (2002) 1785-1788
32. Jodoin J., Laroche-Pierre S., Goodyer C.G., and LeBlanc A.C. Defective retrotranslocation causes loss of anti-Bax function in human familial prion protein mutants. J. Neurosci 27 (2007) 5081-5091
33. Lopez C.D., Yost C.S., Prusiner S.B., Myers R.M., and Lingappa V.R. Unusual topogenic sequence directs prion protein biogenesis. Science 248 (1990) 226-229
34. Yost C.S., Lopez C.D., Prusiner S.B., Myers R.M., and Lingappa V.R. Non-hydrophobic extracytoplasmic determinant of stop transfer in the prion protein. Nature 343 (1990) 669-672
35. Kim S.J., Rahbar R., and Hegde R.S. Combinatorial control of prion protein biogenesis by the signal sequence and transmembrane domain. J. Biol. Chem 276 (2001) 26132-26140
36. Ott C.M., and Lingappa V.R. Signal sequences influence membrane integration of the prion protein. Biochemistry 43 (2004) 11973-11982
37. Hegde R.S., Mastrianni J.A., Scott M.R., DeFea K.A., Tremblay P., Torchia M., DeArmond S.J., Prusiner S.B., and Lingappa V.R. A transmembrane form of the prion protein in neurodegenerative disease. Science 279 (1998) 827-834
38. Hegde R.S., Voigt S., and Lingappa V.R. Regulation of protein topology by trans-acting factors at the endoplasmic reticulum. Mol. Cell 2 (1998) 85-91
39. Hegde R.S., and Lingappa V.R. Regulation of protein biogenesis at the endoplasmic reticulum membrane. Trends Cell Biol 9 (1999) 132-137
40. Gu Y., Luo X., Basu S., Fujioka H., and Singh N. Cell-specific metabolism and pathogenesis of transmembrane prion protein. Mol. Cell Biol 26 (2006) 2697-2715
41. Gu Y., Singh A., Bose S., and Singh N. Pathogenic mutations in the glycosylphosphatidylinositol signal peptide of PrP modulate its topology in neuroblastoma cells. Mol. Cell Neurosci 37 (2008) 647-656
42. Kascsak R.J., Rubenstein R., Merz P.A., Tonna-DeMasi M., Fersko R., Carp R.I., Wisniewski H.M., and Diringer H. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J. Virol 61 (1987) 3688-3693
43. Rogers M., Serban D., Gyuris T., Scott M., Torchia T., and Prusiner S.B. Epitope mapping of the Syrian hamster prion protein utilizing chimeric and mutant genes in a vaccinia virus expression system. J. Immunol 147 (1991) 3568-3574
44. Barry R.A., and Prusiner S.B. Monoclonal antibodies to the cellular and scrapie prion proteins. J. Infect Dis 154 (1986) 518-521
45. Groger R.K., Morrow D.M., and Tykocinski M.L. Directional antisense and sense cDNA cloning using Epstein-Barr virus episomal expression vectors. Gene 81 (1989) 285-294
46. LeBlanc A. Increased production of 4 kDa amyloid beta peptide in serum deprived human primary neuron cultures: possible involvement of apoptosis. J. Neurosci 15 (1995) 7837-7846
47. Paradis E., Douillard H., Koutroumanis M., Goodyer C., and LeBlanc A. Amyloid ß peptide of Alzheimer's disease downregulates Bcl-2 and upregulates Bax expression in human neurons. J. Neurosci 16 (1996) 7533-7539
48. Harlow E., and Lane D. Using Antibodies Vol. 1 (1999), Cold Spring Harbor Laboratory Press, Cold Spring Harbor
49. Chen S.G., Teplow D.B., Parchi P., Teller J.K., Gambetti P., and Autilio-Gambetti L. Truncated forms of the human prion protein in normal brain and in prion diseases. J. Biol. Chem 270 (1995) 19173-19180
50. Ott C.M., Akhavan A., and Lingappa V.R. Specific features of the prion protein transmembrane domain regulate nascent chain orientation. J. Biol. Chem 282 (2007) 11163-11171
51. Holscher C., Bach U.C., and Dobberstein B. Prion protein contains a second endoplasmic reticulum targeting signal sequence located at its C terminus. J. Biol. Chem 276 (2001) 13388-13394
52. Mouillet-Richard S., Ermonval M., Chebassier C., Laplanche J.L., Lehmann S., Launay J.M., and Kellermann O. Signal transduction through prion protein. Science 289 (2000) 1925-1928
53. Zanata S.M., Lopes M.H., Mercadante A.F., Hajj G.N., Chiarini L.B., Nomizo R., Freitas A.R., Cabral A.L., Lee K.S., Juliano M.A., de Oliveira E., Jachieri S.G., Burlingame A., Huang L., Linden R., Brentani R.R., and Martins V.R. Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. Embo J 21 (2002) 3307-3316
54. Chiarini L.B., Freitas A.R., Zanata S.M., Brentani R.R., Martins V.R., and Linden R. Cellular prion protein transduces neuroprotective signals. Embo J 21 (2002) 3317-3326
55. Hegde R.S., Tremblay P., Groth D., DeArmond S.J., Prusiner S.B., and Lingappa V.R. Transmissible and genetic prion diseases share a common pathway of neurodegeneration. Nature 402 (1999) 822-826
56. Kim S.J., and Hegde R.S. Cotranslational partitioning of nascent prion protein into multiple populations at the translocation channel. Mol. Biol. Cell 13 (2002) 3775-3786
57. Stewart R.S., Drisaldi B., and Harris D.A. A transmembrane form of the prion protein contains an uncleaved signal peptide and is retained in the endoplasmic reticulum. Mol. Biol. Cell 12 (2001) 881-889
58. Schneiter R., and Toulmay A. The role of lipids in the biogenesis of integral membrane proteins. Appl Microbiol Biotechnol 73 (2007) 1224-1232
59. Fons R.D., Bogert B.A., and Hegde R.S. Substrate-specific function of the translocon-associated protein complex during translocation across the ER membrane. J. Cell Biol 160 (2003) 529-539
60. Stockton J.D., Merkert M.C., and Kellaris K.V. A complex of chaperones and disulfide isomerases occludes the cytosolic face of the translocation protein Sec61p and affects translocation of the prion protein. Biochemistry 42 (2003) 12821-12834
61. Kurschner C., and Morgan J.I. The cellular prion protein (PrP) selectively binds to Bcl-2 in the yeast two-hybrid system. Brain Res. Mol. Brain Res 30 (1995) 165-168
62. Kurschner C., and Morgan J. Analysis of interaction sites in homo- and heteromeric complexes containing Bcl-2 family members and the cellular prion protein. Mol. Br. Res 37 (1996) 249-258
63. Oltvai Z.N., Milliman C.L., and Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74 (1993) 609-619
64. Dlugosz P.J., Billen L.P., Annis M.G., Zhu W., Zhang Z., Lin J., Leber B., and Andrews D.W. Bcl-2 changes conformation to inhibit Bax oligomerization. Embo J 25 (2006) 2287-2296
65. Liao H.J., and Carpenter G. Role of the Sec61 translocon in EGF receptor trafficking to the nucleus and gene expression. Mol. Biol. Cell 18 (2007) 1064-1072
66. Nizard P., Tetley S., Le Drean Y., Watrin T., Le Goff P., Wilson M.R., and Michel D. Stress-induced retrotranslocation of clusterin/ApoJ into the cytosol. Traffic 8 (2007) 554-565
67. Abujarour R.J., Dalal S., Hanson P.I., and Draper R.K. p97 Is in a complex with cholera toxin and influences the transport of cholera toxin and related toxins to the cytoplasm. J. Biol. Chem 280 (2005) 15865-15871